Emergent received a $22 million federal order to develop an early-stage Zika vaccine, which could be ready for trials by early next year.
“Glad the government can rely on us sufficiently to come to us a second and third time to help them with a health crisis,” said Barbara Solow, Emergent BioSolutions.
The Gaithersburg-based company has been called on several times to help during a global virus outbreak, developing a number of vaccines — including anthrax and Ebola.
More
3 comments:
and there you have it.. the whole zika bs.
why all of a sudden out of nowhere.
$$$$$
coming soon to a drive thru near you.
get your zika, flu, hpv shots all at once, you don't even have to get out of your car!
does anybody realize how ridiculous you all are, how masterful the drug companies are. drive thru the parking lot and for $10 we will shoot you up, with a concoction that we do not disclose, that usually doesn't work, and you don't even have to get out of your car.
Brilliant
Of course they are. Let's see if it works like the flu vaccine.
That thing looks like it came out of a Clinton!
Post a Comment